companydata.dkcompanydata.dk

Medivatus Group ApS: Financial statements 2025

CVR: 40644482

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Medivatus Group ApS (CVR 40644482) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -32,614 compared with DKK -297,261 the year before. Equity in the 2025 report amounted to DKK 215,753. The solvency ratio was 98.2%.

Profit/Loss
DKK -32,614
Equity
DKK 215,753
Total Assets
DKK 219,684
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-0-33 t.216 t.0
2024-0-297 t.573 t.-
2023-34 t.-336 t.870 t.-
2022-958 t.2.1 mio.1.2 mio.1
2021-1.8 mio.-2.2 mio.-883 t.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Medivatus Group ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Medivatus Group ApS: The 2024 annual report is outMay 21, 2025

Medivatus Group ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK -297,261.

About Medivatus Group ApS

Medivatus Group ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Helle Katrine Jørgensen and David Gareth Martin. The company is owned by Assegai Holding AS. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -32,614 compared with DKK -297,261 the year before. Equity in the 2025 report amounted to DKK 215,753.

Source: annual report 2025, Danish Business Authority

Other financial years